Picture of Advanced Oncotherapy logo

AVO Advanced Oncotherapy Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Advanced Oncotherapy, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-13.7-21.1-20.8-25.3-29.5
Depreciation
Non-Cash Items-0.1366.12.086.849.5
Discontinued Operations
Other Non-Cash Items
Changes in Working Capital3.8512.9-6.86-4.12-11.9
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-9.59-1.66-23.6-20.2-29.6
Capital Expenditures-8.56-12.1-12-7.44-9.29
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00.0130.3260.0030
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-8.56-12.1-11.7-7.43-9.29
Financing Cash Flow Items0.009-0.626-0.665-1.061
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities16.814.737.526.740.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.390.9572.22-0.9181.94